Early detection saves lives.
Let’s start with yours.

To get started, ask to talk to a HALO Patient Navigator at your imaging center.

Know More. Act Sooner.

HALO’s Genetic and Breast Pathways help detect risk for inherited cancer predispositions and provide personalized insights - so you can take control of your health early. Ask for your Patient Navigator at your center offering Halo Pathways.

Genetic Testing Gave Me Clarity, Confidence, and Control

Kavita, HALO Patient and employee

Kavita’s story

“Knowing my results was the better option, rather than living in doubt. Genetic testing gave me peace of mind and the power to make informed decisions—not just for myself, but for my future family.”

When cancer is caught sooner,
treatment success is higher.

1 in 8 women

will be diagnosed with breast cancer in their lifetime.

1 in 6 people

meet genetic testing criteria, but only a small faction have had genetic testing.

1 in 9 men

will be diagnosed with prostate cancer in their lifetime.

The leading cause of death

for both men and women is cardiovascular disease

Is Inherited Cancer Risk a Factor for You?

The average person has up to a 40% chance of developing cancer during their lifetime.⁴

However, your family history may increase your personal risk—so it’s important to start by reviewing it carefully.

Do close relatives (parents, siblings, children, grandparents, aunts, uncles, nieces, nephews) have a history of cancer? Specifically, breast, ovarian, prostate, pancreatic, colon, endometrial (uterine, not cervical), or stomach (gastric) cancer?

Anyone diagnosed before age 50?

Did any close relative have more than one cancer?

Is there a history of rare types of cancer in the family, such as male breast cancer, pancreatic or ovarian cancer?

Meet Mary

How HALO helped a patient get their health back on track

Mary’s father’s mother passed away from breast cancer at 45. After turning 35, her doctor recommended a mammogram. Mary also had the HALO Genetic Health PathWay™ cancer genetic test.

What does this mean for Mary?

Mary tested positive for a BRCA2 variant, which increases the risk of breast and other cancers.⁵ Her HALO Nurse Practitioner recommended a screening breast MRI, in line with established standard of care. While Mary’s mammogram was normal, the MRI detected breast cancer early, leading to successful treatment.

How does this impact Mary’s family?

Mary shared her results with her family so they, too, could take action for personalized screening and prevention. Her siblings and children each had a 50% chance of carrying the same variant. In line with standard of care, her family was recommended to consider genetic testing.

How much does testing cost?

Most commercial and federally funded insurance plans cover cancer predisposition testing, and the majority of patients have no out of pocket costs, when certain criteria are met. For those who do have out-of-pocket expenses, we offer options to make testing accessible and affordable.

Early detection saves lives. Let’s start with yours.

Ask for your Patient Navigator at your center offering Halo Pathways.

Understanding Your Risk:
BRCA2 and Cancer Screening

A single gene variant can increase the risk for several different types of cancer. HALO Precision Diagnostics focuses on genes that have consensus screening guidelines established – so the results can lead to clear, actionable next steps. The table below summarizes cancer risks associated with BRCA2 variants.

Cancer	Lifetime Risk	Screening highlights from the National Comprehensive Cancer Network*
Breast (Women)	45–69%	Annual breast MRI beginning at age 25, add mammogram at 30
Ovarian	11–17%	Limitations of available screening Speak with your healthcare provider to discuss risk reducing options
Male Breast	6–7%	Annual breast exam from 35; consider annual mammogram starting at age 50, or earlier depending on family history
Prostate	20–30%	Consider baseline PSA (Prostate Specific Antigen) and DRE (Digital Rectal Exam) beginning at age 40; with follow-up dependent on results
Pancreatic	2–5%	Screening can be considered, if there is close relative who was diagnosed; age to start depends on age at diagnosis of relative
Melanoma	Possibly increased	Consider yearly skin checks

* to be reviewed in detail with your healthcare providers if a BRCA2 variant is identified